HEALTHY VOLUNTEERS NEEDED FOR INVESTIGATIONAL SHIGELLA PHAGE STUDY
Seeking healthy adults aged 18-50 for an investigational oral phage product against shigella. Study duration will be approximately 5 months. Volunteers will drink placebo or study product 3 times per day for 7 days, complete a study diary, 6 outpatient visits and 2 phone calls. Compensation up to $1,505 for qualified volunteers.
LEARN MORE: cvdtrials.org/shigella32k
Intralytix, Inc.'s EcoActive™ bacteriophage therapy targeting adhesive invasive E. coli (AIEC) in Crohn's disease patients has entered a Phase 1/2a clinical trial at the Icahn School of Medicine at the Mount Sinai Hospital in New York, NY. The trial, registered under clinicaltrials.gov NCT03808103, is currently recruiting volunteers with inactive Crohn's disease.
For questions on the phage study, please contact the study coordinator at Amy.firstname.lastname@example.org.
See one of the trial's clinical investigators and IBD expert, Dr. Robert Hirten, discuss this exciting new bacteriophage therapy trial at: https://www.facebook.com/mountsinainyc